ADDEX N/ CH0029850754 /
2024-08-05 4:05:52 PM | Chg. +0.0012 | Volume | Bid6:41:10 PM | Ask6:41:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.0594CHF | +2.06% | 101,801 Turnover: 5,968.0012 |
0.0570Bid Size: 64,500 | 0.0600Ask Size: 1,000 | 10.59 mill.CHF | - | - |
GlobeNewswire
06-06
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-31
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
04-18
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
04-11
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire
04-03
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire
01-31
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire
2023-11-23
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...